Cyrus Biotechnology
Cyrus Biotechnology develops computationally engineered biologics from natural proteins for therapeutic applications, with lead programs targeting severe autoimmune diseases and acute respiratory distress syndrome. The company uses protein design algorithms and laboratory methods to create novel variants and fusion proteins, aiming to provide superior efficacy and address unmet medical needs.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2014
- Type
- Corporation Seattle business license
- Employees
- 17
- Registered name
- Cyrus Biotechnology Inc Seattle business license
- Stage
- Series B
- Members see funding amounts. .
- Founders
- David Baker
Is this your organization? Claim it
Members see Cyrus Biotechnology's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Lucas Nivon Executive Officer, Director, Co-Founder and Chief Executive Officer
-
Yifan Song Director, Co-founder and Chief Technology Officer
-
Erik Procko Executive, Chief Scientific Officer